Itt's Earnings Call Contradictions: Spx Flow Margin Progression and Middle East Conflict Impact at Odds

Date of Call: Aug 6, 2026

Financials Results

• Revenue: $1.5B, up 51% YOY (13% organic)
• EPS: $2.08 per adjusted diluted share, up 18% YOY
• Operating Margin: 21.4% for Flow Technologies, down 160 bps YOY due to SPX Flow dilution; CCT margin 21.7%, up 100 bps YOY

Guidance:

• Organic revenue growth raised to 5-8% for full year 2026.
• Adjusted operating margin expected to expand over 100 bps to ~20.5% midpoint.
• Adjusted EPS outlook raised to $8.22 at midpoint, up 14% YOY.
• Free cash flow guidance midpoint raised to $565M, margin 10-11%.
• Target leverage ratio ~2.3x by year-end.

Business Commentary:

Strong Financial Performance and Growth:

• ITT reported a 51% increase in revenue for the second quarter, with 13% organic growth, and expanded operating margin by 40 basis points.
• The growth was driven by strong performance across its portfolio, including significant contributions from acquisitions and operational execution.

Defense and Aerospace Orders Surge:

• The company's CCT segment grew 59% organically, fueled by large defense orders in the Quesaria business, with significant multi-year bookings in areas like advanced night vision applications and fighter jet programs.
• The increase was attributed to strong demand in defense and aerospace sectors, supported by market share gains and new platform wins.

Flow Technologies and Project Shipment Growth:

• Flow technologies reported a 21% organic growth in revenue, driven by strong project shipments and short cycle sales, with pump project sales up 45%.
• This growth was due to increased demand in marine energy transition and oil and gas markets, alongside successful integration and performance of acquired assets like SPX Flow.

Capital Allocation and Debt Reduction:

• ITT prioritized debt repayment, reducing its leverage ratio to 2.5 times, six months ahead of its original commitment.
• The company's focus on capital allocation was aimed at enhancing financial stability and shareholder value, alongside strategic acquisitions to secure supply chain resilience.

Increased Guidance and Outlook:

• The company raised its full-year organic revenue guidance to 5-8% growth, adjusted operating margin to approximately 20.5%, and adjusted EPS outlook to $8.22 at the midpoint.
• This optimistic outlook was based on increased bookings, strong project and short cycle performance, and ongoing productivity initiatives.

Sentiment Analysis:

Overall Tone: Positive

• Management highlighted 'strong performance across the portfolio,' 'record quarter,' and 'accelerating momentum.' They noted raising guidance across revenue, margin, and EPS, and expressed confidence in acquisitions compounding value. Luca Savi stated: 'Our acquisition playbook is indeed working.'

Q&A:

• Question from Scott Davis (Melius Research): Can you give a sense of where SPX Flow is in their lean and operational excellence journey and where the upside is?
  Response: SPX Flow plants have good 5S and talent but need to embed lean practices more deeply into operations for greater productivity gains.

• Question from Jeff Hammond (KeyBank Capital Markets): What is driving underlying demand momentum in SPX Flow and can you expand on the funnel comment?
  Response: SPX Flow order growth is driven by strong mixers and chemicals recovery, with a growing funnel of opportunities geographically across North America and Europe.

• Question from Mike Halloran (Baird): Can you help with back half cadence for earnings/revenue and order visibility?
  Response: Expect elevated performance to continue in H2; CCT has long-term program visibility, Flow Tech and SPX Flow are building backlog, Motion Tech expects stable margins.

• Question from Daniel DiCicco (BMO Capital Markets): Where do you see the most opportunity for market share gains in the medium term?
  Response: Opportunities remain across the portfolio, particularly in Flow Technologies and CCT, with potential to grow faster in those areas.

• Question from Joe Giordano (TD Cowan): What is the opportunity to bring SPX Flow products into legacy biopharma wins?
  Response: Cross-selling SPX Flow valves and mixers to biopharma markets is a potential sales synergy being pursued.

• Question from Nathan Jones (Stiefel): Where is SPX Flow on their 80-20 journey and value-based pricing?
  Response: Management prefers a '100-20' approach, focusing on common sense business savvy, and SPX Flow team is capable of value-based pricing.

• Question from Vlad Bistricki (Citigroup): How much of SPX Flow growth is volume vs. price, and how is price contributing to organic growth overall?
  Response: SPX Flow growth is mainly volume with some price; overall, ITT's price-cost equation remains positive, especially in Flow Tech.

• Question from Andrew Obin (Bank of America): Why do you feel better about margins in the second half, and is H2 organic growth too conservative?
  Response: Margin improvement expected from Flow Tech synergies and productivity; H2 growth considers tougher YOY comparisons, fewer days in Q4, and Middle East order delays, but full-year guidance is raised.

• Question from Joe Ritchie (Goldman Sachs): What does the M&A pipeline look like, and is business mix shifting to longer cycle?
  Response: Priorities remain debt repayment and synergy execution, but small bolt-on acquisitions are in the pipeline; backlog visibility is strong for both short and long term.

Contradiction Point 1

SPX Flow Margin Progression and Normalization

Contradiction on whether SPX Flow margins will normalize or continue expanding, impacting financial forecasts and investor expectations.

What were the primary factors contributing to the company's financial performance in Q4? - Andrew Obin (Bank of America)

2026Q2: The Q2 margin was slightly impacted by dilution from SPX Flow. However, significant margin expansion is expected in H2 as cost synergies and productivity initiatives ramp up. - Luca Savi(CEO)

What factors contribute to the increased confidence in margins for the second half? - Julian Mitchell (Analyst, Barclays)

2026Q1: The high Q1 margin for SPX Flow was boosted by a 5-week March; margins are expected to normalize in subsequent quarters but will improve with productivity plans. - Emmanuel Caprais(CFO) & Luca Savi(CEO)

Contradiction Point 2

Middle East Conflict Business Impact and Outlook

Contradiction on the severity of near-term impact versus long-term opportunity, affecting strategic outlook and risk assessment.

Joe Giordano (TD Cowen) - Joe Giordano (TD Cowen)

2026Q2: Short-term revenue may be impacted by order delays. However, shifts could create long-term opportunities... and LNG flow changes could be favorable... - Luca Savi(CEO)

How will Middle East geopolitical shifts impact ITT's business? - Joe Giordano (Analyst)

2026Q1: ITT does not see air pockets because the business is broad and diversified, and defense modernization is a long-term trend in both the U.S. and Europe. - Luca Savi(CEO)

Contradiction Point 3

Industrial Process (IP) Order Funnel Health

Contradiction on the current health and geographic strength of the IP order funnel, influencing demand momentum assessments.

How is KeyBank Capital Markets performing in terms of earnings? - Jeff Hammond (KeyBank Capital Markets)

2026Q2: The order funnel is growing across North America and Europe, supported by a book-to-bill ratio above 1%. - Luca Savi(CEO)

What is driving the underlying demand momentum and order growth for SPX Flow? - Matt Summerville (Analyst, D.A. Davidson)

2026Q1: The IP funnel is healthy and elevated, up year-over-year and sequentially, especially in North America (orders grew 10% there). It is down in Europe/Middle East due to frozen conversations... - Luca Savi(CEO)

Contradiction Point 4

Order Funnel and Visibility Outlook

Contradiction on the stability and growth trajectory of the order funnel, affecting revenue visibility and business planning.

Mike Halloran (Baird) - Mike Halloran (Baird)

2026Q2: The order strength provides strong visibility... The backlog for Q3, Q4, and Q1 next year is considerably higher than last year's, providing excellent near-term visibility. - Mike Savinelli(CFO)

What is the expected cadence for earnings and revenue in the second half, and how are orders tracking in terms of visibility and conversion? - Jeffrey Hammond (KeyBanc Capital Markets Inc.)

2025Q4: The order funnel is slightly down year-over-year but stable within the quarter. - Luca Savi(CEO)

Contradiction Point 5

Auto Market Production Outlook and Visibility

Contradiction on near-term auto production visibility and its impact on business, affecting market segment assessments.

Mike Halloran (Baird) - Mike Halloran (Baird)

2026Q2: The order strength provides strong visibility... **Motion Technologies & Connectors:** Winning awards that feed future market share gains and rail/defense strength. - Mike Savinelli(CFO)

What is the expected cadence for earnings and revenue in the second half, and how are orders tracking in terms of visibility and conversion? - Joseph Giordano (TD Cowen)

2025Q3: Europe's auto production grew slightly in Q3 but is **forecast down ~2% for 2025**. Customers are facing investment challenges but also opportunities for new models. **Chip shortages (e.g., Nexperia) are not yet directly impacting ITT's customers**. - Luca Savi(CEO)